Work

SMK-002 inhibits the growth of bladder cancer cells and increases their sensitivity to Osimertinib via enhancing epidermal growth factor receptor degradation

Year: 2025

Type: article

Abstract: , providing a novel strategy for the potential treatment of BC.

Source: Korean Journal of Physiology and Pharmacology

DOI: 10.4196/kjpp.25.071

Authors: Xiaochen Zhou, Yizhi Bu, Di Xiao, Duo Li, Xiaoping Yang

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

Funders: National Natural Science Foundation of China, Hunan Normal University, Key Research and Development Program of Hunan Province of China

Awards: G2859541188, G5251204119, G7121622566

OpenAlex ID: W4416978206

FWCI:

Cites:

Cited by:

Related to: